Consistently, Febuxostat at 2.5 mg/kg/day for 12 weeks significantly inhibited plasma XO activity, reduced atherosclerotic plaque formation, and decreased macrophage infiltration in the aortic root, indicating protection against atherosclerosis in ApoE−/− mice fed a high-cholesterol diet [187]. This evidence concerns the gene APOE and atherosclerosis.